Capital expenditure increased 56.0%
Capital expenditure changed +56.0% from the comparable as-filed period. The change ranks at the 43th percentile of 7 prior comparable changes.
$52,249→$81,5217 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →SOTK financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents increased 84.7%
Cash & equivalents changed +84.7% from the comparable as-filed period.
$4.9M→$9.0M2 prior comparisons
Free-cash-flow proxy increased 290.8%
Free-cash-flow proxy changed +290.8% from the comparable as-filed period. The change ranks at the 71th percentile of 7 prior comparable changes.
-$974,542→$1.9M7 prior comparisons
Gross margin moved 486 bp higher
Gross margin changed +486 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
51.91%→56.77%4 prior comparisons
Gross profit increased 20.6%
Gross profit changed +20.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$2.7M→$3.2M4 prior comparisons
Inventory decreased 14.4%
Inventory changed -14.4% from the comparable as-filed period.
$4.7M→$4.1M3 prior comparisons
Net income increased 52.8%
Net income changed +52.8% from the comparable as-filed period.
$484,985→$741,1683 prior comparisons
Operating cash flow increased 310.4%
Operating cash flow changed +310.4% from the comparable as-filed period. The change ranks at the 71th percentile of 7 prior comparable changes.
-$922,293→$1.9M7 prior comparisons
Operating income increased 85.6%
Operating income changed +85.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$483,368→$897,1604 prior comparisons
Operating margin moved 643 bp higher
Operating margin changed +643 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
9.42%→15.85%4 prior comparisons
Revenue increased 10.3%
Revenue changed +10.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$5.1M→$5.7M4 prior comparisons
Research & development decreased 7.7%
Research & development changed -7.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$668,470→$616,9824 prior comparisons
Stock-based compensation increased 14.2%
Stock-based compensation changed +14.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$75,163→$85,8254 prior comparisons
Capex / revenue moved 42 bp higher
Capex / revenue changed +42 basis points from the comparable as-filed period.
1.02%→1.44%3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.